7Baggers
 published on: 2025-11-16 07:04:03  newser.com Sun, 16 Nov 2025 13:04:03 GMT
 Published on: 2025-11-15 04:32:00  newser.com Sat, 15 Nov 2025 10:32:00 GMT
 d pipeline - trade signal summary & high win rate trade tips  newser.com Sat, 15 Nov 2025 07:57:16 GMT
 published on: 2025-11-14 17:28:55  newser.com Fri, 14 Nov 2025 23:28:55 GMT
 Third Arc Bio licenses Adagene tech for CD3 T-cell engagers  BioWorld MedTech Fri, 14 Nov 2025 19:28:19 GMT
 Published on: 2025-11-14 13:23:12  newser.com Fri, 14 Nov 2025 19:23:12 GMT
 Adagene inks milestone-heavy T-cell engager pact with Third Arc Bio  FirstWord Pharma Thu, 13 Nov 2025 21:32:30 GMT
 Adagene inks licensing deal with Third Arc Bio  The Pharma Letter Thu, 13 Nov 2025 16:39:44 GMT
 Adagene Announces Licensing Agreement with Third Arc Bio  GlobeNewswire Thu, 13 Nov 2025 12:00:00 GMT
 12 Health Care Stocks Moving In Tuesday's Intraday Session  Benzinga Tue, 11 Nov 2025 17:09:17 GMT
 published on: 2025-11-10 05:05:40  newser.com Mon, 10 Nov 2025 11:05:40 GMT
 published on: 2025-11-09 13:00:25  newser.com Sun, 09 Nov 2025 19:00:25 GMT
 published on: 2025-11-07 10:04:09  newser.com Fri, 07 Nov 2025 16:04:09 GMT
 published on: 2025-11-05 21:04:13  newser.com Thu, 06 Nov 2025 03:04:13 GMT
 adagene inc. (adag) analyst insights, price targets and recommendations  Yahoo Finance UK Wed, 05 Nov 2025 20:43:28 GMT
 published on: 2025-11-05 03:32:46  newser.com Wed, 05 Nov 2025 09:32:46 GMT

Adagene Inc
(NASDAQ:ADAG) 

ADAG stock logo

Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. Its products include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase Ib clinical trials for the ...

Founded: 2011
CEO: Peter Luo  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends